Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system

N Jakowenko, S Nguyen, M Ruegger, A Dinh… - Thrombosis research, 2020 - Elsevier
Abstract Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses
without the need for routine laboratory monitoring. Anti-Xa assays can estimate …
被引用次数：30 相关文章

Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system.

N Jakowenko, S Nguyen, M Ruegger, A Dinh… - Thrombosis …, 2020 - europepmc.org
Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses without the
need for routine laboratory monitoring. Anti-Xa assays can estimate anticoagulant effect for …
[HTML] nih.gov

[HTML][HTML] Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system

N Jakowenko, S Nguyen, M Ruegger, A Dinh… - Thrombosis …, 2020 - ncbi.nlm.nih.gov
Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses without the
need for routine laboratory monitoring. Anti-Xa assays can estimate anticoagulant effect for …

Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system

N Jakowenko, S Nguyen, M Ruegger… - Thrombosis …, 2020 - thrombosisresearch.com
Abstract Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses
without the need for routine laboratory monitoring. Anti-Xa assays can estimate …

Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system

N Jakowenko, S Nguyen, M Ruegger… - Thrombosis …, 2020 - scholars.uthscsa.edu
Background: Oral factor Xa inhibitors (FXaI) can be administered in fixed doses without the
need for routine laboratory monitoring. Anti-Xa assays can estimate anticoagulant effect for …

Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system

N Jakowenko, S Nguyen, M Ruegger… - Thrombosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Oral factor Xa inhibitors (FXaI) can be administered in fixed doses without the
need for routine laboratory monitoring. Anti-Xa assays can estimate anticoagulant effect for …